# Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial

> **NCT02053740** · PHASE4 · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 59 (actual)

## Conditions studied

- Immune Dysfunction

## Interventions

- **DRUG:** Add R-S-Y-R-T (500 mg 3 times per day) for 6 months
- **DRUG:** Routine western medicine

## Key facts

- **NCT ID:** NCT02053740
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-08
- **Final completion:** —
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02053740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02053740, "Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02053740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*